Review




Structured Review

Boston Scientific Corporation madit ii datasets
Estimated ICERs and 95% CIs for the MADIT-CRT <t>and</t> <t>MADIT-II</t> trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Madit Ii Datasets, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/madit+ii+datasets/pmc13164937-355-12-16?v=Boston+Scientific+Corporation
Average 86 stars, based on 1 article reviews
madit ii datasets - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs"

Article Title: Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs

Journal: Biometrics

doi: 10.1093/biomtc/ujag073

Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Figure Legend Snippet: Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Techniques Used:



Similar Products

86
Boston Scientific Corporation madit ii datasets
Estimated ICERs and 95% CIs for the MADIT-CRT <t>and</t> <t>MADIT-II</t> trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).
Madit Ii Datasets, supplied by Boston Scientific Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/madit+ii+datasets/pmc13164937-355-12-16?v=Boston+Scientific+Corporation
Average 86 stars, based on 1 article reviews
madit ii datasets - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Journal: Biometrics

Article Title: Regression methods for cost-effectiveness analysis with different censoring times or terminating events for survival time and costs

doi: 10.1093/biomtc/ujag073

Figure Lengend Snippet: Estimated ICERs and 95% CIs for the MADIT-CRT and MADIT-II trials. The dots represent 1000 bootstrap samples. The solid lines denote the estimated ICERs; the black dashed lines and the gray dot-dashed lines indicate CI limits obtained by the IMP method and the bootstrap method, respectively. Panels (A) and (B) present results using HF-free QAL as the effectiveness measure for the LBBB and non-LBBB subgroups in the MADIT-CRT study (4-year time horizon). Panel (C) presents results using YOL as the effectiveness measure in the MADIT-II study (3.5-year time horizon).

Article Snippet: While the data transfer and use agreements prohibit making the MADIT-CRT and MADIT-II datasets publicly available, Boston Scientific may share the data with qualified researchers, available at https://www.bostonscientific.com/en-US/data-sharing-requests.html

Techniques: